World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
36336
World Ranking
9607
National Ranking
4950

Overview

Alan C. Swann is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily spans the fields of Medicine, Psychology, and Neuroscience, with significant focus on Clinical Psychology, Pharmacology, Psychiatry and Mental Health, Cognitive Neuroscience, and Experimental and Cognitive Psychology.

The scientist's work frequently addresses topics such as Treatment of Major Depression, Suicide and Self-Harm Studies, Functional Brain Connectivity Studies, Bipolar Disorder and Treatment, Tryptophan and Brain Disorders, Mental Health Research Topics, and Child and Adolescent Psychosocial and Emotional Development.

Recent publications include:

  • The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management, 2022, World Psychiatry
  • Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder, 2021, JAMA Psychiatry
  • Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial, 2021, American Journal of Psychiatry
  • Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial, 2021, Neuropsychopharmacology
  • Impulsivity and Suicidal Behavior, 2020, Current topics in behavioral neurosciences

Frequent coauthors with whom they have collaborated include:

  • Sanjay J. Mathew
  • Thomas R. Kosten
  • Nicholas Murphy
  • Marijn Lijffijt
  • David P. Graham

The scientist's work is regularly published in venues such as Biological Psychiatry, Neuropsychopharmacology, Journal of Affective Disorders, JAMA Psychiatry, and American Journal on Addictions.

Best Publications

  • Psychiatric aspects of impulsivity

    F. Gerard Moeller;Ernest S. Barratt;Donald M. Dougherty;Joy M. Schmitz

  • Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania

    Charles L. Bowden;Andrew M. Brugger;Alan C. Swann;Joseph R. Calabrese

  • A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder

    Charles L. Bowden;Joseph R. Calabrese;Susan L. McElroy;Laszlo Gyulai

  • A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder

    Joseph R. Calabrese;Trisha Suppes;Charles L. Bowden;Gary S. Sachs

  • Characteristics of impulsive suicide attempts and attempters

    Thomas R. Simon;Alan C. Swann;Kenneth E. Powell;Lloyd B. Potter

  • Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania.

    McElroy Sl;Keck Pe;Pope Hg;Hudson Ji

  • Depression During Mania: Treatment Response to Lithium or Divalproex

    Alan C. Swann;Charles L. Bowden;David Morris;Joseph R. Calabrese

  • Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

    I.G. McKeith;C.G. Ballard;R.H. Perry;P.G. Ince

  • Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder.

    Alan C. Swann;Donald M. Dougherty;Peggy J. Pazzaglia;Mary Pham

  • Two models of impulsivity: relationship to personality traits and psychopathology.

    Alan C. Swann;James M. Bjork;F.Gerard Moeller;Donald M. Dougherty

  • Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

    K. Lobotesis;J.D. Fenwick;A. Phipps;A. Ryman

  • A double-blind comparison of valproate and lithium in the treatment of acute mania.

    T W Freeman;J L Clothier;P Pazzaglia;M D Lesem

  • Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments

    M. Margallo-Lana;A. Swann;J. O'Brien;A. Fairbairn

  • P50, N100, and P200 sensory gating: Relationships with behavioral inhibition, attention, and working memory

    Marijn Lijffijt;Scott D. Lane;Stacey L. Meier;Nash N. Boutros

  • Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

    Clive Ballard;Marisa Margallo-Lana;Edmund Juszczak;Simon Douglas

  • Impulsivity: a link between bipolar disorder and substance abuse.

    Alan C Swann;Donald M Dougherty;Peggy J Pazzaglia;Mary Pham

  • The Texas Implementation of Medication Algorithms: Update to the Algorithms for Treatment of Bipolar I Disorder

    Trisha Suppes;Ellen B. Dennehy;Robert M A Hirschfeld;Lori L. Altshuler

  • Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.

    Peter E. Stokes;Peter M. Stoll;Stephen H. Koslow;James W. Maas

  • Impulsivity and phase of illness in bipolar disorder

    Alan C. Swann;Peggy Pazzaglia;Anna Nicholls;Donald M. Dougherty

  • The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

    Charles E. Begley;John F. Annegers;Alan C. Swann;Christopher Lewis

Frequent Co-Authors

F. Gerard Moeller
F. Gerard Moeller Virginia Commonwealth University
Nachum Dafny
Nachum Dafny The University of Texas Health Science Center at Houston
Donald M. Dougherty
Donald M. Dougherty The University of Texas Health Science Center at San Antonio
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Joel L. Steinberg
Joel L. Steinberg Virginia Commonwealth University
Scott D. Lane
Scott D. Lane The University of Texas Health Science Center at Houston
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University
James M. Bjork
James M. Bjork Virginia Commonwealth University
Susan L. McElroy
Susan L. McElroy University of Cincinnati Medical Center
Charles W. Mathias
Charles W. Mathias The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t just mean becoming a doctor. There are many online degree pathways in the healthcare field that offer flexibility, competitive salaries, and the chance to make a real impact—even before or beyond earning an MD.

For example, those interested in mental health care may consider online msn pmhnp programs, which prepare graduates to become Psychiatric Mental Health Nurse Practitioners. These programs provide a faster and more flexible option for nurses seeking to specialize in mental health.

If you’re drawn to the business side of healthcare, pursuing a healthcare administration degree cost is an important consideration. These degrees help you move into leadership or management positions at hospitals, clinics, or other healthcare organizations.

Aspiring executives can explore the masters in healthcare administration cost to find affordable options that offer a pathway toward healthcare leadership. For nurses wanting the highest level of practice, dnp online programs cheap can provide a cost-effective route to advanced clinical positions.

These diverse online degree options open up a variety of rewarding and in-demand healthcare careers.

Best Scientists Citing Alan C. Swann

Trending Scientists

Recently Published Articles